A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)

G. M. H. E. Dackus; P. C. Schouten; J. J. Geenen; S. Marchetti; G. S. Sonke; S. C. Linn; J. H. M. Schellens

doi:10.1158/1538-7445.SABCS15-OT1-03-10

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)

G. M. H. E. Dackus
, P. C. Schouten
, J. J. Geenen
, S. Marchetti
, G. S. Sonke
, S. C. Linn
, J. H. M. Schellens

Department of Pathology

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Cancer Research
Volume	76
DOIs	https://doi.org/10.1158/1538-7445.SABCS15-OT1-03-10
Publication status	Published - 15 Feb 2016

Access to Document

10.1158/1538-7445.SABCS15-OT1-03-10

Cite this

Dackus, G. M. H. E., Schouten, P. C., Geenen, J. J., Marchetti, S., Sonke, G. S., Linn, S. C., & Schellens, J. H. M. (2016). A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study). Cancer Research, 76. https://doi.org/10.1158/1538-7445.SABCS15-OT1-03-10

@article{90e4470ba2aa47b39b135c2115994b54,

title = "A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)",

author = "Dackus, \{G. M. H. E.\} and Schouten, \{P. C.\} and Geenen, \{J. J.\} and S. Marchetti and Sonke, \{G. S.\} and Linn, \{S. C.\} and Schellens, \{J. H. M.\}",

year = "2016",

month = feb,

day = "15",

doi = "10.1158/1538-7445.SABCS15-OT1-03-10",

language = "English",

volume = "76",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

}

Dackus, GMHE, Schouten, PC, Geenen, JJ, Marchetti, S, Sonke, GS, Linn, SC & Schellens, JHM 2016, 'A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)', Cancer Research, vol. 76. https://doi.org/10.1158/1538-7445.SABCS15-OT1-03-10

A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study). / Dackus, G. M. H. E.; Schouten, P. C.; Geenen, J. J. et al.
In: Cancer Research, Vol. 76, 15.02.2016.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study)

AU - Dackus, G. M. H. E.

AU - Schouten, P. C.

AU - Geenen, J. J.

AU - Marchetti, S.

AU - Sonke, G. S.

AU - Linn, S. C.

AU - Schellens, J. H. M.

PY - 2016/2/15

Y1 - 2016/2/15

U2 - 10.1158/1538-7445.SABCS15-OT1-03-10

DO - 10.1158/1538-7445.SABCS15-OT1-03-10

M3 - Meeting Abstract

SN - 0008-5472

VL - 76

JO - Cancer Research

JF - Cancer Research

ER -

Dackus GMHE, Schouten PC, Geenen JJ, Marchetti S, Sonke GS, Linn SC et al. A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA-1 or-2 mutated Her2 negative advanced breast cancer as first line treatment (REVIVAL study). Cancer Research. 2016 Feb 15;76. doi: 10.1158/1538-7445.SABCS15-OT1-03-10